{
    "Overall_score": {
        "Correlation": 9,
        "Sentiment": 2,
        "Importance": 8,
        "Impact": 7,
        "Duration": 5,
        "Virality": 6,
        "Source_Score": 7,
        "Specificity": 9,
        "Sector_Spread": 4,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "@megtirrell: $AMGN says FOCUS trial of Kyprolis didn't meet primary endpoint of improving overall survival in multiple myeloma/$LGND",
            "Correlation": 10,
            "Sentiment": 1,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 3,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$AMGN FOCUS fails",
            "Correlation": 9,
            "Sentiment": 2,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 7,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 4,
            "Tech_Mentions": 3
        },
        {
            "News_content": "RT @MarketWatch: $AMGN has a double dose of bad news for investors, causing shares to drop 2% after the close",
            "Correlation": 9,
            "Sentiment": 3,
            "Importance": 8,
            "Impact": 7,
            "Duration": 4,
            "Virality": 8,
            "Source_Score": 9,
            "Specificity": 7,
            "Sector_Spread": 5,
            "Tech_Mentions": 4
        }
    ]
}